The Norwegian Register of Persons Assessed for Cognitive Symptoms in Specialist Health Care Services (NorCog)
Progression of Alzheimer’s disease and resource use (the PADR study).
Trajectories in real life and risk factors of dementia (Trail-Dem)
Importance of low-grade inflammation in patients with cognitive impairment due to Alzheimer’s disease and stroke (Inflamdem)
Qualitative EEG as a prognostic tool in MCI (NORD-MCI)
Disentangle subtypes of Alzheimer’s disease using structural MRI modalities- a cross-sectional and longitudinal study (SAS-MRI study)
18F-Flutemetamol PET/CT for the diagnosis of Alzheimer’s disease - clinical value and reference levels
Early biomarker of Alzheimer’s disease using single-molecule detection
Neuroplasticity in mild cognitive impairment. Longitudinal effects of adaptive working memory training, genetic markers and novel interventions.
Vitamin D and its relationship to cognition, neuropsychiatric symptoms and dementia markers in older persons.
Spatial orientation in persons with mild cognitive impairment and Alzheimer’s disease.
Discovering elderly at risk of developing depression: can Locus of Control give a reliable prediction of depression amongst those with a dementia diagnosis?
Activity in dementia - needs and neuropsychiatric symptoms (A-DEM)
Aksnes M, Edwin TH, Saltvedt I, Eldholm RS, Chaudhry FA, Halaas NB, Myrstad M, Watne LO, Knapskog AB(2023) Sex-specific associations of matrix metalloproteinases in Alzheimer's disease Biol Sex Differ, 14(1), 35 DOI 10.1186/s13293-023-00514-x, PubMed 37221606
Chwiszczuk LJ, Breitve MH, Kirsebom BB, Selnes P, Fløvig JC, Knapskog AB, Skogseth RE, Hubbers J, Holst-Larsen E, Rongve A(2023) The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trial Front Aging Neurosci, 15, 1163184 DOI 10.3389/fnagi.2023.1163184, PubMed 37304077
Knapskog AB, Aksnes M, Edwin TH, Ueland PM, Ulvik A, Fang EF, Eldholm RS, Halaas NB, Saltvedt I, Giil LM, Watne LO(2023) Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's disease Alzheimers Dement(in press) DOI 10.1002/alz.13162, PubMed 37264981